En colaboración con

ABLE Human Motion es miembro de la Sociedad Industrial Internacional en Tecnología de Rehabilitación AvanzadaIISART es una asociación dedicada al avance y promoción de la tecnología sanitaria en rehabilitación en beneficio del paciente y la sociedad, que agrupa a las empresas líderes del sector. IISART representa los intereses de los desarrolladores, fabricantes y comercializadores de dispositivos médicos en el campo de la robótica y la tecnología sanitaria avanzada en rehabilitación y se esfuerza por hacerlo en interacción con todas las partes interesadas.

ABLE Human Motion es miembro de la Sociedad Industrial Internacional en Tecnología de Rehabilitación AvanzadaIISART es una asociación dedicada al avance y promoción de la tecnología sanitaria en rehabilitación en beneficio del paciente y la sociedad, que agrupa a las empresas líderes del sector. IISART representa los intereses de los desarrolladores, fabricantes y comercializadores de dispositivos médicos en el campo de la robótica y la tecnología sanitaria avanzada en rehabilitación y se esfuerza por hacerlo en interacción con todas las partes interesadas.

Apoyado por

EIT Health Headstart 2018 Funding

This activity has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union’s Horizon 2020 research and innovation programme.

H2020 SME Instrument Phase 1 (2018)
The project “ABLE: Home use, affordable and lightweight exoskeleton for people with lower-limb paralysis” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 855081.

Ayuda a Contratos Torres Quevedo 2018
Este proyecto ha recibido la Ayuda a Contratos Torres Quevedo 2018, para el investigador Joan Lobo Prat, referencia PTQ2018-010227, financiada por MCIN/AEI/10.13039/501100011033.

Programa NEOTEC-CDTI 2019
El proyecto “ABLE: el primer exoesqueleto ligero, fácil de usar y económico que permite volver a caminar”, con expediente EXP – 00123363 / SNEO-20191281, ha recibido financiación de la convocatoria 2019 del programa NEOTEC del Centro para el Desarrollo Tecnológico y la Innovación (CDTI).

EIT Health ́s Start-up Amplifier Instrument
The activity “ABLE Exoskeleton” (ID 20121 and 211013) has received funding from EIT Health in the 2020-2022 period. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union receives support from the European Union ́s Horizon 2020 Research and innovation programme.

DIH Hero Technology Demonstrator 2019
“ABLE After Stroke: ABLE Exoskeleton to Empower Independence and Rehabilitation After Stroke” is a Technology Demonstrator that received funding from the European Union’s Horizon 2020 research and innovation programme under the DIH-HERO (Digital Innovation Hubs in Healthcare Robotics) grant agreement no 825003.

EUROBENCH FSTP-2
“TestABLE: TESTing the performance of the ABLE exoskeleton in several Eurobench scenarios” is a FSTP-2 sub-project of the EUropean Robotic framework for bipedal locomotion bENCHmarking (EUROBENCH) project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 779963.

CAIXAIMPULSE
The project has received funding from “la Caixa” Foundation under the programs: CaixaImpulse Validate 2017 (LCF/TR/CI17/50020001, “CI17-00009 ABLE: Assistive Biorobotic Low-cost Exoskeleton”) and CaixaImpulse Consolidate 2020 (LCF/TR/CC20/52480002, “CF92-00010 ABLE REGAIN: Robotic Exoskeleton for Gait trAining with Intensive Neurorehabilitation after stroke”).

DIH Hero Technology Demonstrator 2022
“EngageABLE: Enhancing the capabilities of the ABLE Exoskeleton to promote users’ motivation and faster learning” is a Technology Demonstrator that received funding from the European Union’s Horizon 2020 research and innovation programme under the DIH-HERO (Digital Innovation Hubs in Healthcare Robotics) grant agreement no 825003.

EUROSTARS 3 – Call 2
El proyecto “1789 REACTION: Robotic assisted balance and exoskeleton training in neurorehabilitation” ha recibido financiación del programa conjunto Eurostars-3 con cofinanciación de CDTI y del Programa Marco de Investigación e Innovación Horizonte Europa de la Unión Europea.

Colaboración Público-Privada 2021
El proyecto “ABLE Daily Exo: La nueva generación de exoesqueletos robóticos inteligentes para ayudar a las personas con discapacidad en las actividades de la vida diaria” con número de expediente CPP2021-008429 ha sido financiado por MCIN/AEI/10.13039/501100011033 y por la Unión Europea NextGenerationEU/ PRTR.

Chips JU 2022
The project “101112347 NerveRepack: Intelligent neural system for bidirectional connection with exoprostheses and exoskeletons” has received funding from the European Union’s HORIZON Europe research and innovation programme under grant agreement No 101112347, Chips Joint Undertaking (Chips JU), Research and Innovation Actions (RIA).

Investigo AGAUR 2023
Este proyecto ha recibido financiación del Programa Investigo 2023 para la contratación de personas jóvenes demandantes de empleo, financiado por la Unión Europea – Next Generation EU en el marco del Plan Nacional de Recuperación, Transformación y Resiliencia.

EUROSTARS 3 – Call 5
El proyecto “5214 FREEDOM: First exoskeleton specifically adapted for multiple sclerosis” ha recibido financiación del programa conjunto Eurostars-3 con cofinanciación de CDTI y del Programa Marco de Investigación e Innovación Horizonte Europa de la Unión Europea.

EIT Health Headstart 2018 Funding

This activity has received funding from the European Institute of Innovation and Technology (EIT). This body of the European Union receives support from the European Union’s Horizon 2020 research and innovation programme.

H2020 SME Instrument Phase 1 (2018)
The project “ABLE: Home use, affordable and lightweight exoskeleton for people with lower-limb paralysis” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 855081.

Ayuda a Contratos Torres Quevedo 2018
Este proyecto ha recibido la Ayuda a Contratos Torres Quevedo 2018, para el investigador Joan Lobo Prat, referencia PTQ2018-010227, financiada por MCIN/AEI/10.13039/501100011033.

Programa NEOTEC-CDTI 2019
El proyecto “ABLE: el primer exoesqueleto ligero, fácil de usar y económico que permite volver a caminar”, con expediente EXP – 00123363 / SNEO-20191281, ha recibido financiación de la convocatoria 2019 del programa NEOTEC del Centro para el Desarrollo Tecnológico y la Innovación (CDTI).

EIT Health ́s Start-up Amplifier Instrument
The activity “ABLE Exoskeleton” (ID 20121 and 211013) has received funding from EIT Health in the 2020-2022 period. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union receives support from the European Union ́s Horizon 2020 Research and innovation programme.

DIH Hero Technology Demonstrator 2019
“ABLE After Stroke: ABLE Exoskeleton to Empower Independence and Rehabilitation After Stroke” is a Technology Demonstrator that received funding from the European Union’s Horizon 2020 research and innovation programme under the DIH-HERO (Digital Innovation Hubs in Healthcare Robotics) grant agreement no 825003.

EUROBENCH FSTP-2
“TestABLE: TESTing the performance of the ABLE exoskeleton in several Eurobench scenarios” is a FSTP-2 sub-project of the EUropean Robotic framework for bipedal locomotion bENCHmarking (EUROBENCH) project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 779963.

CAIXAIMPULSE
The project has received funding from “la Caixa” Foundation under the programs: CaixaImpulse Validate 2017 (LCF/TR/CI17/50020001, “CI17-00009 ABLE: Assistive Biorobotic Low-cost Exoskeleton”) and CaixaImpulse Consolidate 2020 (LCF/TR/CC20/52480002, “CF92-00010 ABLE REGAIN: Robotic Exoskeleton for Gait trAining with Intensive Neurorehabilitation after stroke”).

DIH Hero Technology Demonstrator 2022
“EngageABLE: Enhancing the capabilities of the ABLE Exoskeleton to promote users’ motivation and faster learning” is a Technology Demonstrator that received funding from the European Union’s Horizon 2020 research and innovation programme under the DIH-HERO (Digital Innovation Hubs in Healthcare Robotics) grant agreement no 825003.

EUROSTARS 3 – Call 2
El proyecto “1789 REACTION: Robotic assisted balance and exoskeleton training in neurorehabilitation” ha recibido financiación del programa conjunto Eurostars-3 con cofinanciación de CDTI y del Programa Marco de Investigación e Innovación Horizonte Europa de la Unión Europea.

Colaboración Público-Privada 2021
El proyecto “ABLE Daily Exo: La nueva generación de exoesqueletos robóticos inteligentes para ayudar a las personas con discapacidad en las actividades de la vida diaria” con número de expediente CPP2021-008429 ha sido financiado por MCIN/AEI/10.13039/501100011033 y por la Unión Europea NextGenerationEU/ PRTR.

Chips JU 2022

The project “101112347 NerveRepack: Intelligent neural system for bidirectional connection with exoprostheses and exoskeletons” has received funding from the European Union’s HORIZON Europe research and innovation programme under grant agreement No 101112347, Chips Joint Undertaking (Chips JU), Research and Innovation Actions (RIA).

Investigo AGAUR 2023
Este proyecto ha recibido financiación del Programa Investigo 2023 para la contratación de personas jóvenes demandantes de empleo, financiado por la Unión Europea – Next Generation EU en el marco del Plan Nacional de Recuperación, Transformación y Resiliencia.

EUROSTARS 3 – Call 5
El proyecto “5214 FREEDOM: First exoskeleton specifically adapted for multiple sclerosis” ha recibido financiación del programa conjunto Eurostars-3 con cofinanciación de CDTI y del Programa Marco de Investigación e Innovación Horizonte Europa de la Unión Europea.

¿Interesado en ser colaborador clínico nuestro?

Siempre estamos buscando nuevas instituciones clínicas
que nos ayuden a probar y mejorar nuestra tecnología.

¿Interesado en ser

colaborador clínico nuestro?

Siempre estamos buscando nuevas instituciones clínicas
que nos ayuden a probar y mejorar nuestra tecnología.
Request a Demo


    What describes you the best?:

    First name *

    Last name *

    Email *

    Phone number *

    Country *


    Name of your Clinical Institution? *

    Type of Clinical Institution *

    What is your Position? *

    How did you hear about us? *

    Please provide information on what you are looking for: *

    By sending the form above, I agree that the data it contains will be stored and processed by ABLE Human Motion to respond to my request according to the purposes described in the Privacy Policy.


    Name of the Clinical Institution you went to? *

    Cause of impairment?

    In the case of SCI: Level of injury?

    How did you hear about us? *

    What are you looking for?: *

    We are currently developing a new version of the exoskeleton for personal use, to walk at home or in the community, which we plan to launch in the market in the year 2026. Do you want to collaborate with us? Contact us:


    By sending the form above, I agree that the data it contains will be stored and processed by ABLE Human Motion to respond to my request according to the purposes described in the Privacy Policy.


    Distributor Name *

    Do you sell other robotic rehabilitation products?*

    Which ones: *

    How did you hear about us? *

    Please provide information on what you are looking for: *

    By sending the form above, I agree that the data it contains will be stored and processed by ABLE Human Motion to respond to my request according to the purposes described in the Privacy Policy.

    X